du-21220 has been researched along with cl 316243 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akahane, M; Akahane, S; Hirabayashi, A; Miyata, H; Mukaiyama, H; Muranaka, H; Tamai, T; Tanaka, N | 1 |
| Clouse, AK; Hieble, JP; Riedel, E; Westfall, TD | 1 |
| Jóźwik, M; Kleszczewski, T; Kostrzewska, A; Modzelewska, B; Pędzińska-Betiuk, A; Sulkowski, S | 1 |
3 other study(ies) available for du-21220 and cl 316243
| Article | Year |
|---|---|
Discovery of novel N-phenylglycine derivatives as potent and selective beta(3)-adrenoceptor agonists for the treatment of frequent urination and urinary incontinence.
Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Female; Ferrets; Glycine; Heart Rate; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Pregnancy; Pressure; Rats; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Structure-Activity Relationship; Urinary Bladder; Urinary Incontinence; Urination; Uterus | 2001 |
The effects and selectivity of beta-adrenoceptor agonists in rat myometrium and urinary bladder.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Dioxoles; Dose-Response Relationship, Drug; Ethanolamines; Female; In Vitro Techniques; Muscle Contraction; Muscle Relaxation; Myometrium; Oxytocics; Oxytocin; Potassium Chloride; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Ritodrine; Urinary Bladder; Uterine Contraction | 2007 |
Altered uterine contractility in response to β-adrenoceptor agonists in ovarian cancer.
Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Dioxoles; Endometrial Neoplasms; Ethanolamines; Female; Humans; Middle Aged; Ovarian Neoplasms; Receptors, Adrenergic, beta; Ritodrine; Uterine Contraction | 2017 |